News

N.B.1.8.1, dubbed “razor blade throat,” is the current dominant variant in the U.S. It's an offshoot of XVD.1.5.1, which is a descendant of the omicron variant.
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
The Food and Drug Administration Thursday granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and ...
The Health and Human Services chief and the growing authoritarianism within the department are already seeding future danger.
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines.
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...
Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...